XML 21 R7.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities    
Net income $ 54,069 $ 18,973
Adjustment to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 50,452 52,052
Amortization of contract acquisition costs 751 1,183
Amortization of debt issuance costs 909 744
Imputed interest expense and fair value adjustments to contingent consideration 207 8,204
Provision for doubtful accounts   483
(Gain) loss on disposal of assets 182 25
Impairment losses 3,569 1,120
Impairment of equity investment   15,632
Gain (adjustment) on bargain purchase of a business   (685)
Non-cash loss on assets held for sale reclassified to assets held and used   2,000
Deferred income taxes (1,354) (5,276)
Excess tax benefit from equity-based awards (1,242) (708)
Equity-based compensation expense 9,663 9,292
(Gain) loss on foreign currency derivatives (155) 659
Changes in assets and liabilities, net of acquisitions:    
Accounts receivable 36,705 77,186
Prepaids and other assets 21,425 (39,752)
Accounts payable and accrued expenses 83,986 14,777
Deferred revenue and other liabilities (74,770) 10,200
Net cash provided by operating activities 184,397 166,109
Cash flows from investing activities    
Proceeds from sale of long-live assets 355 21
Purchases of property, plant and equipment (44,438) (31,841)
Investments in non-marketable equity investments   (2,119)
Acquisitions, net of cash acquired of zero and $4.5 million, respectively   (2,027)
Net cash used in investing activities (44,083) (35,966)
Cash flows from financing activities    
Proceeds from line of credit 746,800 1,573,500
Payments on line of credit (829,800) (1,645,000)
Payments on other debt (9,367) (4,613)
Payments of contingent consideration and hold back payments to acquisitions (5,902) (785)
Dividends paid to shareholders (13,864) (12,414)
Payments to noncontrolling interest (3,600) (2,025)
Capital contribution from noncontrolling interest 3,362  
Proceeds from exercise of stock options   208
Tax payments related to issuance of restricted stock units (5,413) (4,618)
Payments of debt issuance costs (1,819) (35)
Net cash (used in) provided by financing activities (119,603) (95,782)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (3,151) (14,919)
Increase (decrease) in cash, cash equivalents and restricted cash 17,560 19,442
Cash, cash equivalents and restricted cash, beginning of period 78,237 74,437
Cash, cash equivalents and restricted cash, end of period 95,797 93,879
Supplemental disclosures    
Cash paid for interest 9,901 13,677
Cash paid for income taxes 25,076 30,088
Non-cash investing and financing activities    
Acquisition of long lived assets through finance leases 3,172 11,482
Acquisition of equipment through increase in accounts payable, net (493) 1,056
Dividends declared but not paid $ 14,875 $ 12,932